• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    More On TSPT

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Transcept Pharmaceuticals, Inc. (TSPT)

    -NasdaqGM
    1.70 Oct 30, 3:59PM EDT
    Add to Portfolio
    Prev Close:1.70
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:4.20
    Beta:2.03
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:1.55 - 3.88
    Volume:0
    Avg Vol (3m):73,328
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    TSPT 0.00%N/A
    APRI53.22M
    PTIE91.97M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    As of October 30, 2014, Transcept Pharmaceuticals, Inc. was acquired by Paratek Pharmaceuticals, Inc., in a reverse merger transaction. Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commerciali... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback